ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
β-Caryophyllene protects male fertility and testicular function against paclitaxel-induced damage in a murine model.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
β-Caryophyllene (BCP) is a naturally occurring dietary sesquiterpene found in various edible plants and spices, such as clove, black pepper, and cinnamon, and is noted for its strong antioxidant and anti-inflammatory effects. Nevertheless, its preventive function against chemotherapy-induced male reproductive damage has not been sufficiently investigated. This study examined the functional dietary potential of BCP in alleviating paclitaxel (PTX)-induced testicular damage and explained its underlying molecular mechanisms. Five groups of male rodents were randomly assigned: control, BCP alone, PTX, PTX + BCP (low dose), and PTX + BCP (high dose). We assessed oxidative stress markers in the testicles and used Western blotting to examine the protein levels of p-AMPK, SIRT3, Nrf2, and markers of apoptosis. Histopathological changes, collagen accumulation, and apoptotic cell death were assessed via hematoxylin-eosin, Masson's trichrome, and TUNEL tests, respectively. PTX administration significantly altered testicular homeostasis, as indicated by inhibited p-AMPK/SIRT3/Nrf2 signaling, reduced antioxidant enzyme activities, heightened lipid peroxidation and oxidative DNA damage, increased proinflammatory cytokines, and augmented apoptosis. These molecular alterations were associated with significant histological deterioration, excessive collagen accumulation, diminished serum testosterone concentrations, decreased testicular coefficient, and compromised sperm quality. Notably, BCP co-treatment dose dependently restored antioxidant capacity, reactivated p-AMPK/SIRT3/Nrf2 signaling, suppressed inflammatory and apoptotic responses, and protected testicular architecture and reproductive function. BCP alone did not cause any bad effects. β-Caryophyllene, a bioactive dietary ingredient, demonstrates substantial protective benefits against PTX-induced testicular toxicity through the activation of the p-AMPK/SIRT3/Nrf2 pathway. These results underscore BCP as a viable functional food-derived adjuvant for ameliorating chemotherapy-induced male reproductive failure.
Indexed as
Identifiers
42702658What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.